
### [MONDO:0021249](http://purl.obolibrary.org/obo/MONDO_0021249)
**Label:** lip neoplasm

**Subclasses:** [MONDO:0021333](http://purl.obolibrary.org/obo/MONDO_0021333) (carcinoma of lip), [MONDO:0020562](http://purl.obolibrary.org/obo/MONDO_0020562) (pleomorphic liposarcoma), [MONDO:0020563](http://purl.obolibrary.org/obo/MONDO_0020563) (Dedifferentiated liposarcoma), [MONDO:0003602](http://purl.obolibrary.org/obo/MONDO_0003602) (intracranial liposarcoma), [MONDO:0004636](http://purl.obolibrary.org/obo/MONDO_0004636) (lip carcinoma in situ), [MONDO:0004436](http://purl.obolibrary.org/obo/MONDO_0004436) (myxoid liposarcoma of the ovary), [MONDO:0003589](http://purl.obolibrary.org/obo/MONDO_0003589) (liposarcoma of the ovary), [MONDO:0003600](http://purl.obolibrary.org/obo/MONDO_0003600) (cutaneous liposarcoma), [MONDO:0006834](http://purl.obolibrary.org/obo/MONDO_0006834) (lip cancer), [MONDO:0002634](http://purl.obolibrary.org/obo/MONDO_0002634) (liposarcoma of bone), [MONDO:0003601](http://purl.obolibrary.org/obo/MONDO_0003601) (mediastinum liposarcoma), [MONDO:0003587](http://purl.obolibrary.org/obo/MONDO_0003587) (pediatric liposarcoma), [MONDO:0003588](http://purl.obolibrary.org/obo/MONDO_0003588) (larynx liposarcoma), [MONDO:0005103](http://purl.obolibrary.org/obo/MONDO_0005103) (well-differentiated liposarcoma), [MONDO:0003585](http://purl.obolibrary.org/obo/MONDO_0003585) (adult liposarcoma), [MONDO:0003586](http://purl.obolibrary.org/obo/MONDO_0003586) (esophagus liposarcoma), [MONDO:0004510](http://purl.obolibrary.org/obo/MONDO_0004510) (inflammatory liposarcoma), [MONDO:0006312](http://purl.obolibrary.org/obo/MONDO_0006312) (myofibroma), [MONDO:0004673](http://purl.obolibrary.org/obo/MONDO_0004673) (lower lip cancer), [MONDO:0021496](http://purl.obolibrary.org/obo/MONDO_0021496) (benign neoplasm of lip), [MONDO:0020561](http://purl.obolibrary.org/obo/MONDO_0020561) (myxoid/round cell liposarcoma), [MONDO:0005060](http://purl.obolibrary.org/obo/MONDO_0005060) (liposarcoma), [MONDO:0013280](http://purl.obolibrary.org/obo/MONDO_0013280) (myxoid liposarcoma), [MONDO:0021427](http://purl.obolibrary.org/obo/MONDO_0021427) (squamous cell carcinoma of lip), [MONDO:0004621](http://purl.obolibrary.org/obo/MONDO_0004621) (upper lip cancer), [MONDO:0005238](http://purl.obolibrary.org/obo/MONDO_0005238) (round cell liposarcoma), [MONDO:0003599](http://purl.obolibrary.org/obo/MONDO_0003599) (vulvar liposarcoma), [MONDO:0003596](http://purl.obolibrary.org/obo/MONDO_0003596) (spindle cell liposarcoma), [MONDO:0003597](http://purl.obolibrary.org/obo/MONDO_0003597) (mixed-type liposarcoma), [MONDO:0003594](http://purl.obolibrary.org/obo/MONDO_0003594) (mixed liposarcoma), [MONDO:0003592](http://purl.obolibrary.org/obo/MONDO_0003592) (gastric liposarcoma), [MONDO:0003593](http://purl.obolibrary.org/obo/MONDO_0003593) (breast liposarcoma), [MONDO:0003590](http://purl.obolibrary.org/obo/MONDO_0003590) (fibroblastic liposarcoma), [MONDO:0003591](http://purl.obolibrary.org/obo/MONDO_0003591) (kidney liposarcoma), 

**Mapped go classes:** [GO:0036488](http://purl.obolibrary.org/obo/GO_0036488) (CHOP-C/EBP complex), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0046890](http://purl.obolibrary.org/obo/GO_0046890) (regulation of lipid biosynthetic process), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:1990622](http://purl.obolibrary.org/obo/GO_1990622) (CHOP-ATF3 complex), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0035976](http://purl.obolibrary.org/obo/GO_0035976) (transcription factor AP-1 complex), [GO:1990617](http://purl.obolibrary.org/obo/GO_1990617) (CHOP-ATF4 complex), [GO:0070059](http://purl.obolibrary.org/obo/GO_0070059) (intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress), 

**Class expressions from DL-Learner:**

- [GO:1990622](http://purl.obolibrary.org/obo/GO_1990622) (CHOP-ATF3 complex) 66.67%
- [GO:1990617](http://purl.obolibrary.org/obo/GO_1990617) (CHOP-ATF4 complex) 66.67%
- [GO:0036488](http://purl.obolibrary.org/obo/GO_0036488) (CHOP-C/EBP complex) 66.67%
- [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex) 55.75%
- [GO:0090575](http://purl.obolibrary.org/obo/GO_0090575) (RNA polymerase II transcription factor complex) 55.69%
- [GO:0032991](http://purl.obolibrary.org/obo/GO_0032991) (macromolecular complex) 54.50%
- [GO:0044798](http://purl.obolibrary.org/obo/GO_0044798) (nuclear transcription factor complex) 53.75%
- [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex) 53.75%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 53.22%
- Thing 51.11%
- [GO:0044428](http://purl.obolibrary.org/obo/GO_0044428) (nuclear part) 39.21%
- [GO:0044446](http://purl.obolibrary.org/obo/GO_0044446) (intracellular organelle part) 37.30%
- [GO:0044422](http://purl.obolibrary.org/obo/GO_0044422) (organelle part) 37.10%
- [GO:0044424](http://purl.obolibrary.org/obo/GO_0044424) (intracellular part) 36.57%
- [GO:0044464](http://purl.obolibrary.org/obo/GO_0044464) (cell part) 36.14%


